{
    "clinical_study": {
        "@rank": "97616", 
        "arm_group": [
            {
                "arm_group_label": "Single incision laparoscopic surgery", 
                "arm_group_type": "Experimental", 
                "description": "Transumbilical single incision laparoscopic surgery will be performed for patients in this group.And addition of only one trocar through the stoma for drainage tube is allowed."
            }, 
            {
                "arm_group_label": "Conventional laparoscopic surgery", 
                "arm_group_type": "Active Comparator", 
                "description": "Conventional laparoscopic surgery for colorectal cancer will be performed for patients in this group."
            }
        ], 
        "brief_summary": {
            "textblock": "-  Compared with traditional open colectomy, laparoscopic surgery is associated with less\n           pain, earlier recovery, and better cosmetic outcome, and its short- and long-term\n           oncologic outcomes have been demonstrated.\n\n        -  In experienced surgeons' hands, single incision laparoscopic surgery is increasingly\n           performed for colorectal disease, and even for malignant lesion because of its reduced\n           incision-associated morbidity and scarring.\n\n        -  However, the safety and efficacy of single incision laparoscopic surgery for colorectal\n           cancer has not yet been evaluated. Thus, the prospective randomized  trial comparing\n           single incision versus conventional laparoscopic surgery for colorectal cancer is\n           needed."
        }, 
        "brief_title": "Safety Study of Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer", 
        "completion_date": {
            "#text": "April 2022", 
            "@type": "Anticipated"
        }, 
        "condition": "Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": "Colorectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years < age < 80 years\n\n          -  Tumor located in rectosigmoid (defined as 10- to 30-cm from the anal verge)\n\n          -  Pathological rectosigmoid carcinoma\n\n          -  Preoperative T stage ranging from T1 to T4a according to the 7th Edition of AJCC\n             Cancer Staging Manual\n\n          -  Tumor size of 5 cm or less; 6) ECOG score is 0-1\n\n          -  ASA socre is \u2160-\u2162\n\n          -  Informed consent\n\n        Exclusion Criteria:\n\n          -  Body mass index (BMI) >30 kg/m2\n\n          -  Pregnant woman or lactating woman\n\n          -  Severe mental disease\n\n          -  Previous abdominal surgery\n\n          -  Emergency operation due to complication (bleeding, perforation or obstruction) caused\n             by colorectal cancer\n\n          -  Requirement of simultaneous surgery for other disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "198", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02117557", 
            "org_study_id": "NFGS-SILS-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Single incision laparoscopic surgery", 
                "intervention_name": "Single incision laparoscopic surgery", 
                "intervention_type": "Procedure", 
                "other_name": "SILS"
            }, 
            {
                "arm_group_label": "Conventional laparoscopic surgery", 
                "intervention_name": "Conventional laparoscopic surgery", 
                "intervention_type": "Procedure", 
                "other_name": "CLS"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Single-incision", 
            "Laparoscopy", 
            "Colorectal Cancer"
        ], 
        "lastchanged_date": "April 17, 2014", 
        "location": {
            "contact": {
                "email": "gzliguoxin@163.com", 
                "last_name": "Guoxin Li, M.D.,PH.D.", 
                "phone": "+86-138-0277-1450"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510-515"
                }, 
                "name": "Nanfang Hospital, Southern Medical University"
            }, 
            "investigator": [
                {
                    "last_name": "Guoxin Li, M.D.,PH.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Yanan Wang, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Haijun Deng, M.D.,PH.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Qi Xue, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Randomized Controlled Trial Comparing Transumbilical Single Incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer", 
        "overall_contact": {
            "email": "gzliguoxin@163.com", 
            "last_name": "Guoxin Li, M.D., PH.D.", 
            "phone": "+86-138-0277-1450"
        }, 
        "overall_contact_backup": {
            "email": "wyn8116@163.com", 
            "last_name": "Yanan Wang, M.D.", 
            "phone": "+86-150-1875-3181"
        }, 
        "overall_official": {
            "affiliation": "Nanfang Hospital, Southern Medical University, China", 
            "last_name": "Guoxin Li, M.D., PH.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The early morbidity rate is defined as the event observed during operation and within 30 days after surgery,", 
            "measure": "Early morbidity rate", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "reference": [
            {
                "PMID": "19966617", 
                "citation": "Bucher P, Pugin F, Morel P. Single-port access laparoscopic radical left colectomy in humans. Dis Colon Rectum. 2009 Oct;52(10):1797-801. doi: 10.1007/DCR.0b013e3181b551ce."
            }, 
            {
                "PMID": "20734083", 
                "citation": "Gash KJ, Goede AC, Chambers W, Greenslade GL, Dixon AR. Laparoendoscopic single-site surgery is feasible in complex colorectal resections and could enable day case colectomy. Surg Endosc. 2011 Mar;25(3):835-40. doi: 10.1007/s00464-010-1275-8. Epub 2010 Aug 24."
            }, 
            {
                "PMID": "22991135", 
                "citation": "Lim SW, Kim HJ, Kim CH, Huh JW, Kim YJ, Kim HR. Umbilical incision laparoscopic colectomy with one additional port for colorectal cancer. Tech Coloproctol. 2013 Apr;17(2):193-9. doi: 10.1007/s10151-012-0900-z. Epub 2012 Sep 19."
            }, 
            {
                "PMID": "23238505", 
                "citation": "Hirano Y, Hattori M, Douden K, Shimizu S, Sato Y, Maeda K, Hashizume Y. Single-incision plus one port laparoscopic anterior resection for rectal cancer as a reduced port surgery. Scand J Surg. 2012;101(4):283-6."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02117557"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Nanfang Hospital of Southern Medical University", 
            "investigator_full_name": "Guoxin Li", 
            "investigator_title": "M.D., Ph.D.", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Operative time, estimated blood loss and incision length are recorded.", 
                "measure": "Operative outcomes", 
                "safety_issue": "Yes", 
                "time_frame": "intraoperative"
            }, 
            {
                "description": "Tumor size, length of proximal and distal margin and lymph nodes harvested are used to assess oncological resection.", 
                "measure": "Pathological outecomes", 
                "safety_issue": "No", 
                "time_frame": "5 days"
            }, 
            {
                "description": "Time to first ambulation, flatus, liquid diet, soft diet, and duration of hospital stay are used to assess the postoperative recoverty course.", 
                "measure": "Postoperative recovery course", 
                "safety_issue": "No", 
                "time_frame": "14 days"
            }, 
            {
                "description": "Postoperative pain is recorded using the visual analog scale (VAS) pain score tool on postoperative day 1, 2, 3 and the day of discharge.", 
                "measure": "Pain score", 
                "safety_issue": "No", 
                "time_frame": "14 days"
            }, 
            {
                "description": "Cosmetic assessment is perform using body image scale and cosmetic scale.", 
                "measure": "Cosmetic assessment", 
                "safety_issue": "No", 
                "time_frame": "14 days"
            }, 
            {
                "measure": "3-year disease free survival rate", 
                "safety_issue": "No", 
                "time_frame": "36 months"
            }, 
            {
                "measure": "5-year overall survival rate", 
                "safety_issue": "No", 
                "time_frame": "60 months"
            }, 
            {
                "measure": "Inflammatory and immune response", 
                "safety_issue": "No", 
                "time_frame": "7 days"
            }
        ], 
        "source": "Nanfang Hospital of Southern Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Guoxin Li", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}